Roundup Cancer Lawsuit – Settlement & Eligibility

Roundup, the glyphosate weed killer made by Monsanto, is the subject of lawsuits alleging it causes non-Hodgkin lymphoma. Bayer, which bought Monsanto in 2018, denies the claims and says decades of studies show glyphosate is safe. A proposed $7.25 billion class settlement went before a St. Louis judge for final approval on September 14, 2026. The judge had not ruled by early October 2026. A federal MDL and thousands of state cases continue. On June 25, 2026, the Supreme Court ruled for Monsanto in a case about Roundup’s cancer-warning label.

Latest Roundup Lawsuit Updates

September 14, 2026: Final Approval Hearing Held in St. Louis

Bayer‘s Monsanto unit went before Judge Timothy Boyer of the St. Louis City Circuit Court in Missouri. It asked for final approval of the proposed Roundup class settlement. Objectors said payouts are too low, and supporters called it the best path to compensation. Reuters reported the judge was not expected to rule [1]. Global Agriculture reported no ruling by early October 2026 [2].

August 27, 2026: Eighth Circuit Rejects Objectors’ Bid for Federal Court

The Eighth Circuit Court of Appeals dismissed objectors’ attempt to move the settlement decision to federal court. Reuters reported this, as carried by Yahoo Finance [3]. That left the final-approval decision with Judge Boyer in St. Louis.

August 5, 2026: Parties Ask to Move Final Approval Hearing

Monsanto and class counsel filed a joint request to move the final-approval hearing from August 19 to September 10, 2026 [4]. Bloomberg Government reported the request. The class settlement hearing had first been set for July 9, 2026. Bayer said the delay would help the parties process opt-out revocation requests that the settlement administrator had received. The court later set the hearing for September 14.

July 9, 2026: Federal Judge Holds MDL Status Conference

U.S. District Judge Vince Chhabria of the Northern District of California held a status conference on the federal Roundup MDL. The MDL covers nearly 4,000 claims [5]. Bayer argued the Supreme Court ruling should end the MDL. Plaintiffs countered that the ruling was limited to Roundup’s label and does not affect design-defect and negligence claims. The judge had called both sides’ first responses “unsatisfying.”

June 25, 2026: Supreme Court Issues 7-2 Ruling for Monsanto

In Monsanto v. Durnell, the justices ruled 7-2 for Monsanto [6]. They held that federal law bars a state-law failure-to-warn claim over Roundup’s label because the EPA has not required a cancer warning, KBTX reported [7]. The ruling reversed a $1.25 million jury award and sent the case back to the lower court. The judgment and mandate issued on July 27, 2026.

March 4, 2026: Judge Grants Preliminary Approval

Bayer said Judge Boyer granted preliminary approval of the class settlement. That started notice to class members and a 90-day period, ending June 4, 2026, to opt out or file objections [8]. All lawsuits in Missouri brought by class members were stayed, except for opt-outs, until the court reaches a final judgment. The judge rejected opposition from a group of lawyers representing roughly 20,000 plaintiffs [9].

February 17, 2026: Monsanto Announces $7.25 Billion Class Settlement

Monsanto announced a proposed nationwide class settlement of current and future Roundup claims alleging non-Hodgkin lymphoma. It would make declining capped annual payments for up to 21 years, totaling up to $7.25 billion, following court approval [10]. Leading plaintiff law firms representing the class filed a motion that day seeking preliminary approval in the Circuit Court of the City of St. Louis.

January 16, 2026: Supreme Court Agrees to Hear Durnell

The U.S. Supreme Court granted Monsanto’s petition in Monsanto v. Durnell. It limited review to whether federal pesticide law preempts a label-based failure-to-warn claim where EPA has not required the warning. Oral argument was April 27, 2026.

September 30, 2025: Missouri Supreme Court Declines Review

The Missouri Supreme Court refused to hear Monsanto’s appeal of a Cole County judgment. The case began as a $1.56 billion jury award, the News Tribune reported [11]. Circuit Judge Daniel Green reduced the award to $611 million, and the Western District Court of Appeals upheld that decision in May 2025. The jury returned its verdict in November 2023.

October 10, 2024: Philadelphia Jury Awards $78 Million

A Philadelphia jury awarded William Melissen of Abington, Pennsylvania, $78 million against Monsanto [12]. The Philadelphia Inquirer reported the verdict. The jury found Roundup was a reason his non-Hodgkin lymphoma developed. The award included $3 million in compensatory damages and $75 million in punitive damages. Monsanto said it disagrees with the verdict and sees strong grounds for appeal. Melissen sued Monsanto and its German parent company, Bayer.

November 17, 2023: Cole County Jury Returns Roundup Verdict

A Cole County jury in Jefferson City, Missouri, awarded more than $1.5 billion in total to former Roundup users. The plaintiffs included James Draeger, Valorie Gunther and Dan Anderson, Tribune News Service reported [13]. The plaintiffs blamed their non-Hodgkin lymphomas on years of using Roundup on their lawns and gardens. Jurors awarded a total of $61.1 million in actual damages and $500 million each in punitive damages.

June 27, 2022: Supreme Court Declines Pilliod Appeal

The U.S. Supreme Court denied Monsanto’s request for review of a California trial loss, The New Lede reported [14]. The Court let stand an $87 million award to Alva and Alberta Pilliod. The Pilliods are a California couple who alleged Roundup caused their non-Hodgkin lymphoma. The jury had originally ordered more than $2 billion in damages for the couple, but the award was later cut by the court.

What Is Non-Hodgkin Lymphoma?

According to the National Cancer Institute‘s patient guide, non-Hodgkin lymphoma is a disease in which malignant (cancer) cells form in the lymph system. It can be indolent or aggressive [15]. Plaintiffs allege that glyphosate, Roundup’s key ingredient, causes this cancer. The EPA calls glyphosate a broad-spectrum herbicide. It is registered for use on many crops and in non-crop sites such as forests, pasture and residential settings [16].

Who May Be Affected?

The proposed class settlement covers people who allege exposure to Roundup before February 17, 2026. They need a medical diagnosis of non-Hodgkin lymphoma, made now or within a 16-year period after final approval [17]. Claimants are people who say they developed cancer after using Roundup at home or on the job, Reuters reported. William Melissen used Roundup often for nearly three decades starting in 1992. He was diagnosed in 2020, the Inquirer reported. An individual legal review can show whether your own facts fit the class.

Reported Injuries or Damages

Plaintiffs allege that Roundup exposure caused their non-Hodgkin lymphoma and that Monsanto failed to warn of the risk. These are allegations, not court findings, and Bayer denies them. A separate page covers Roundup diffuse large B-cell lymphoma lawsuits. The International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans” (Group 2A) in March 2015 [18]. The EPA’s 2017 assessment concluded glyphosate is “not likely to be carcinogenic to humans.”

Evidence to Preserve

Keep records that show when and how you used Roundup or another glyphosate weed killer, and when you were diagnosed:

• Proof that you used Roundup or another glyphosate weed killer, such as receipts, containers, and photos of labels or sprayers.
• Records of where and when you applied the product, including work, landscaping or farm records if your job involved glyphosate.
• Your non-Hodgkin lymphoma diagnosis, including pathology reports, oncology reports, treatment records and dates.
• Medical bills and records of income you lost because of the illness or its treatment.
• Names of people who saw you use Roundup or saw your illness, so they can later confirm what happened.

Filing Deadlines

Time limits for injury claims are set by state law. They depend on where a person lives and on when the exposure, the illness and the diagnosis happened. Some states start the clock at diagnosis. The class settlement has its own opt-out and objection dates, and that period has ended. A late filing can end a claim even if the evidence is strong. Anyone thinking about a claim should talk to a lawyer soon.

Potential Compensation

The proposed settlement offers payouts from $10,000 to $165,000, Reuters reported. Payouts depend on cancer severity, age at diagnosis and whether exposure was at home or work. If a claim succeeds, damages may cover medical bills, lost income and pain and suffering. A San Francisco jury awarded Edwin Hardeman $80 million in March 2019, and Bayer said it would appeal, NPR reported [19]. Compensation amounts vary by case. Past results do not guarantee future outcomes. Potential compensation depends on the claim’s facts and the rules of any settlement program or court.

Frequently Asked Questions

Is There a Roundup Lawsuit Class Action Settlement?

Yes, a Roundup lawsuit class action settlement has been proposed. A 2020 settlement worth approximately $10 billion resolved many existing lawsuits but left Bayer exposed to future claims, Reuters reported. Bayer says the new class differs markedly from a prior class proposal limited to four years.

Did the Supreme Court Rule in the Roundup Case?

Yes, the Supreme Court ruled on a Roundup lawsuit in Monsanto v. Durnell, siding with Monsanto on label-based warning claims. Justices Jackson and Gorsuch dissented, writing that the ruling rests on “a labeling requirement that does not exist.”

What Does the Research Say About Roundup and Cancer?

Research on Roundup and cancer includes the IARC Working Group of 17 experts, which found limited evidence in humans, sufficient evidence in animals and strong evidence for genotoxicity. The EPA is updating its human health risk assessment, with completion anticipated in late 2026.

What Types of Cancer Are Linked to Roundup Lawsuits?

The cancer types linked to Roundup lawsuits are forms of non-Hodgkin lymphoma. The National Cancer Institute describes several types. They include follicular lymphoma, diffuse large B-cell lymphoma, marginal zone lymphoma and mantle cell lymphoma.

How Many Roundup Claims Are Pending?

Approximately 65,000 Roundup claims are pending against Bayer in U.S. state and federal courts, Reuters reported on September 14, 2026. The News Tribune reported more than 60,000 similar claims pending in state courts in July 2026.

Can I Still File a Roundup Lawsuit After the Supreme Court Ruling?

A Roundup lawsuit after the Supreme Court ruling depends on the claim. The ruling covers label-based failure-to-warn claims. Bayer says other claims are variations of that claim, but the federal judge told both sides not to assume the cases will all be dismissed or all move forward.

References

1. https://www.claimsjournal.com/news/national/2026/09/14/340085.htm
2. https://www.global-agriculture.com/crop-protection/bayer-faces-new-missouri-roundup-trial-while-7-25-billion-settlement-awaits-judges-ruling/
3. https://finance.yahoo.com/healthcare/articles/bayer-roundup-7-25-billion-140317759.html
4. https://news.bgov.com/health-law-and-business/bayer-seeks-to-move-roundup-settlement-hearing-to-september-1
5. https://www.newstribune.com/news/2026/jul/09/bayer-seeks-to-end-federal-roundup-litigation/
6. https://www.supremecourt.gov/docket/docketfiles/html/public/24-1068.html
7. https://www.kbtx.com/2026/06/25/supreme-court-blocks-roundup-cancer-lawsuit/
8. https://www.bayer.com/media/en-us/missouri-court-grants-preliminary-approval-of-roundup-class-settlement-to-resolve-current-and-future-claims/
9. https://www.thenewlede.org/2026/03/bayer-wins-preliminary-court-approval-for-its-proposed-roundup-class-action-settlement/
10. https://www.bayer.com/media/en-us/monsanto-announces-roundup-class-settlement-agreement-to-resolve-current-and-future-claims/
11. https://www.newstribune.com/news/2025/oct/10/missouri-supreme-court-refuses-to-review-600/
12. https://inquirer.com/news/monsanto-roundup-weed-killer-verdict-bayer-philadelphia-20241010.html
13. https://www.newstribune.com/news/2023/nov/20/monsanto-ordered-to-pay-15b-in-roundup-case/
14. https://www.thenewlede.org/2022/06/supreme-court-again-rejects-bayer-bid-for-review-of-roundup-loss
15. https://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq
16. https://www.epa.gov/ingredients-used-pesticide-products/glyphosate
17. https://www.dtnpf.com/agriculture/web/ag/crops/article/2026/02/17/bayer-plaintiffs-ask-court-approve-7
18. https://www.iarc.who.int/featured-news/media-centre-iarc-news-glyphosate/
19. https://www.npr.org/2019/03/27/707439575/jury-awards-80-million-in-damages-in-roundup-weed-killer-cancer-trial